Sanofi-Aventis
Sanofi-Aventis articles from Informachine.WHO to review Sanofi’s dengue vaccine Dengvaxia over safety concerns
05 Dec 2017
The review comes after the French pharma giant’s own admission that its dengue vaccine could have unintended consequences in patients who had never been infected with the mosquito-borne virus and the Philippines halted its use
FDA approves Dupixent to treat severe eczema
29 Mar 2017
Stay ahead with Informachine News Trackers! Follow your selected sources, track business news with relevant keywords, and organize seamlessly using labels and bookmarks.
Get the business updates you need, fast, focused, and tailored just for you. Save time, stay informed, and never miss a beat!
Latest articles on Sanofi-Aventis from Informachine
2025-12-17-06-30-00-3206717-en.pdf
17 Dec 2025
2025-12-17-06-00-00-3206714-en.pdf
17 Dec 2025
2025-12-15-06-05-00-3205094-en.pdf
15 Dec 2025
2025-12-15-06-00-00-3205091-en.pdf
15 Dec 2025
2025-12-11-06-00-00-3203611-en.pdf
11 Dec 2025
.css-coveql-MuiSvgIcon-root{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;display:inline-block;fill:currentColor;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;-webkit-transition:fill 20
10 Dec 2025
Global pharmaceutical and healthcare company Sanofi search results.
2025-12-04-10-00-00-3199555-en.pdf
04 Dec 2025
2025-11-14-11-30-00-3188166-en.pdf
14 Nov 2025
2025-11-07-13-00-00-3183599-en.pdf
07 Nov 2025
Science with Purpose
29 Oct 2025
We chase the miracles of science to develop breakthrough innovations in medicines and vaccines for complex diseases including MS, autoimmune, and respiratory conditions.
.webp)
